DPP-4 Inhibitors and Heart Failure: Some Reassurance, Some Uncertainty

被引：24

作者：

Filion, Kristian B.

Suissa, Samy ^{[1
]}

机构：

[1] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada

来源：

DIABETES CARE | 2016年 / 39卷 / 05期

基金：

加拿大健康研究院;

关键词：

INCRETIN-BASED DRUGS; CARDIOVASCULAR OUTCOMES; MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; SITAGLIPTIN; RISK; METFORMIN; HOSPITALIZATION;

D O I：

10.2337/dci15-0036

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：735 / 737

页数：3

共 24 条

[1] 7. Approaches to Glycemic Treatment [J].

不详 .

DIABETES CARE, 2016, 39 :S52-S59

[2] Sitagliptin and cardiovascular outcomes in diabetic patients with chronic kidney disease and acute myocardial infarction: A nationwide cohort study [J].

Chen, Dong-Yi ;

Wang, Szu-Heng ;

Mao, Chun-Tai ;

Tsai, Ming-Lung ;

Lin, Yu-Sheng ;

Chou, Chung-Chuan ;

Wen, Ming-Shien ;

Wang, Chun-Chieh ;

Hsieh, I-Chang ;

Hung, Kuo-Chun ;

Chen, Tien-Hsing .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 181 :200-206

[3] Variations between clinical trial participants and medicare beneficiaries in evidence used for medicare national coverage decisions [J].

Dhruva, Sanket S. ;

Redberg, Rita F. .

ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (02) :136-140

[4] Pancreatic Safety of Incretin-Based Drugs - FDA and EMA Assessment [J].

Egan, Amy G. ;

Blind, Eberhard ;

Dunder, Kristina ;

de Graeff, Pieter A. ;

Hummer, B. Timothy ;

Bourcier, Todd ;

Rosebraugh, Curtis .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (09) :794-797

[5] Confounding by drug formulary restriction in pharmacoepidemiologic research [J].

Filion, Kristian B. ;

Eberg, Maria ;

Ernst, Pierre .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (03) :278-286

[6] Association Between Hospitalization for Heart Failure and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes: An Observational Study [J].

Fu, Alex Z. ;

Johnston, Stephen S. ;

Ghannam, Ameen ;

Tsai, Katherine ;

Cappell, Katherine ;

Fowler, Robert ;

Riehle, Ellen ;

Cole, Ashley L. ;

Kalsekar, Iftekhar ;

Sheehan, John .

DIABETES CARE, 2016, 39 (05) :726-734

[7] Hospitalisation for heart failure and mortality associated with dipeptidyl peptidase 4 (DPP-4) inhibitor use in an unselected population of subjects with type 2 diabetes: a nested case-control study [J].

Giorda, Carlo B. ;

Picariello, Roberta ;

Tartaglino, Barbara ;

Marafetti, Lisa ;

Di Noi, Fabiana ;

Alessiato, Annalisa ;

Costa, Giuseppe ;

Gnavi, Roberto .

BMJ OPEN, 2015, 5 (06)

[8] Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes [J].

Green, Jennifer B. ;

Bethel, M. Angelyn ;

Armstrong, Paul W. ;

Buse, John B. ;

Engel, Samuel S. ;

Garg, Jyotsna ;

Josse, Robert ;

Kaufman, Keith D. ;

Koglin, Joerg ;

Korn, Scott ;

Lachin, John M. ;

McGuire, Darren K. ;

Pencina, Michael J. ;

Standl, Eberhard ;

Stein, Peter P. ;

Suryawanshi, Shailaja ;

Van de Werf, Frans ;

Peterson, Eric D. ;

Holman, Rury R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (03) :232-242

[9] Use of Antidiabetic Drugs in the U. S., 2003-2012 [J].

Hampp, Christian ;

Borders-Hemphill, Vicky ;

Moeny, David G. ;

Wysowski, Diane K. .

DIABETES CARE, 2014, 37 (05) :1367-1374

[10] Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus [J].

Ou, Shuo-Ming ;

Shih, Chia-Jen ;

Chao, Pei-Wen ;

Chu, Hsi ;

Kuo, Shu-Chen ;

Lee, Yi-Jung ;

Wang, Shuu-Jiun ;

Yang, Chih-Yu ;

Lin, Chih-Ching ;

Chen, Tzeng-Ji ;

Tarng, Der-Cherng ;

Li, Szu-Yuan ;

Chen, Yung-Tai .

ANNALS OF INTERNAL MEDICINE, 2015, 163 (09) :663-+

← 1 2 3 →